A new prospective study published in BMC Cancer demonstrates that a novel blood-based multi-omics test, SeekInClarity, can accurately assess and predict therapeutic outcomes in lymphoma patients ...

In fact, demonstration of EBV in the neoplastic cells is a diagnostic requisite in the WHO classification criteria for NK-/T-cell lymphomas. [10] ...

The WHO classification divides NK-cell lymphomas into two histopathological subtypes: extranodal NK-/T-cell lymphoma, nasal type; [10] and aggressive NK-cell leukemia. [14] ...